To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19
Status:
Not yet recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This study is to assess the safety, tolerability, pharmacodynamics, and pharmacokinetics of
Niclosamide (DWRX2003) following escalating doses of DWRX2003 administered as an
intramuscular injection in healthy volunteers.